Stein Kvaløy
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 52
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 13
- Oncology top 2%
- Viral-associated cancers and disorders 9
- Cancer survivorship and care 8
- Neurology top 2%
- CNS Lymphoma Diagnosis and Treatment 13
- Hematology top 5%
-
- Lung Cancer Treatments and Mutations 11
-
- Immune Cell Function and Interaction 10
-
- Monoclonal and Polyclonal Antibodies Research 7
Stein Kvaløy
91 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 106
- Pathology and Forensic Medicine 1.7k
- Genetics 634
- Oncology 1.5k
- Neurology 543
- Hematology 342
Countries citing papers authored by Stein Kvaløy
This map shows the geographic impact of Stein Kvaløy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stein Kvaløy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stein Kvaløy more than expected).
Fields of papers citing papers by Stein Kvaløy
This network shows the impact of papers produced by Stein Kvaløy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stein Kvaløy. The network helps show where Stein Kvaløy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stein Kvaløy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 7 | |
| 2 | 2014 | 32 | |
| 3 | 2013 | 21 | |
| 4 | 2010 | 16 | |
| 5 | 2010 | 104 | |
| 6 | 2009 | 1 | |
| 7 | 2007 | 39 | |
| 8 | 2007 | 19 | |
| 9 | 2004 | 44 | |
| 10 | 2004 | 51 | |
| 11 | 2002 | 189 | |
| 12 | [The radiotherapy satellite in Kristiansand--a model for Norwegian regional hospitals?]. | 2001 | 1 |
| 13 | Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients. | 2001 | 6 |
| 14 | 2000 | 1 | |
| 15 | 1998 | 55 | |
| 16 | 1996 | 26 | |
| 17 | HOYDOSEBEHANDLING MED AUTOLOG STAMCELLESTOTTE VED MALIGNE LIDELSER | 1996 | 1 |
| 18 | 1993 | 11 | |
| 19 | 1992 | 6 | |
| 20 | Cellular antitumor immune response in women with risk factors for breast cancer. | 1979 | 24 |
About Stein Kvaløy
Stein Kvaløy is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Neurology and Hematology, having authored 94 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (52 papers), Chronic Lymphocytic Leukemia Research (13 papers), CNS Lymphoma Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (11 papers), Immune Cell Function and Interaction (10 papers), Viral-associated cancers and disorders (9 papers), Cancer survivorship and care (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.7k citations), Genetics (634 citations), Oncology (1.5k citations), Neurology (543 citations) and Hematology (342 citations). Stein Kvaløy has collaborated with scholars based in Norway, Sweden and United Kingdom. Frequent co-authors include Harald Holte, Ole Nome, Gunnar Kvalheim, A. F. Abrahamsen, Hans Hagberg, Matthew R. Sydes, Knut Lote, Harry C. Schouten, Wendi Qian and Eva Cavallin‐Ståhl. Their work appears in journals such as Annals of Oncology, Bone Marrow Transplantation, Acta Oncologica, Journal of Clinical Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.